Integrated Biopharma Inc (INBP)
0.20
0.00 (0.00%)
USD |
OTCM |
Jun 25, 16:00
Integrated Biopharma Revenue (Quarterly): 13.15M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 13.15M |
| December 31, 2023 | 11.51M |
| September 30, 2023 | 12.92M |
| June 30, 2023 | 12.99M |
| March 31, 2023 | 13.10M |
| December 31, 2022 | 12.25M |
| September 30, 2022 | 12.33M |
| June 30, 2022 | 13.27M |
| March 31, 2022 | 15.63M |
| December 31, 2021 | 14.59M |
| September 30, 2021 | 12.75M |
| June 30, 2021 | 17.06M |
| March 31, 2021 | 17.07M |
| December 31, 2020 | 14.26M |
| September 30, 2020 | 15.17M |
| June 30, 2020 | 13.54M |
| March 31, 2020 | 13.63M |
| December 31, 2019 | 14.20M |
| September 30, 2019 | 11.41M |
| June 30, 2019 | 13.58M |
| March 31, 2019 | 14.09M |
| December 31, 2018 | 12.00M |
| September 30, 2018 | 10.30M |
| June 30, 2018 | 12.56M |
| March 31, 2018 | 10.58M |
| Date | Value |
|---|---|
| December 31, 2017 | 10.80M |
| September 30, 2017 | 9.77M |
| June 30, 2017 | 11.25M |
| March 31, 2017 | 10.65M |
| December 31, 2016 | 12.37M |
| September 30, 2016 | 12.68M |
| June 30, 2016 | 11.38M |
| March 31, 2016 | 10.97M |
| December 31, 2015 | 10.41M |
| September 30, 2015 | 9.445M |
| June 30, 2015 | 8.944M |
| March 31, 2015 | 9.671M |
| December 31, 2014 | 10.29M |
| September 30, 2014 | 8.582M |
| June 30, 2014 | 8.182M |
| March 31, 2014 | 7.522M |
| December 31, 2013 | 8.788M |
| September 30, 2013 | 9.191M |
| June 30, 2013 | 9.596M |
| March 31, 2013 | 8.152M |
| December 31, 2012 | 7.395M |
| September 30, 2012 | 8.48M |
| June 30, 2012 | 7.625M |
| March 31, 2012 | 7.862M |
| December 31, 2011 | 10.24M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
11.41M
Minimum
Sep 2019
17.07M
Maximum
Mar 2021
13.72M
Average
13.40M
Median
Revenue (Quarterly) Benchmarks
| Acme United Corp | 44.96M |
| Bridgford Foods Corp | 47.31M |
| The Hain Celestial Group Inc | 438.36M |
| Better Choice Co Inc | 7.903M |
| Laird Superfood Inc | 9.909M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.285M |
| Total Expenses (Quarterly) | 12.79M |
| EPS Diluted (Quarterly) | 0.01 |
| Enterprise Value | 4.000M |
| Gross Profit Margin (Quarterly) | 9.49% |
| Profit Margin (Quarterly) | 2.17% |
| Earnings Yield | -0.32% |
| Normalized Earnings Yield | -0.316 |